A panel of gene expression biomarkers predicting sustained virologic response (SVR) in chronic hepatitis C patients (CH-C) treated with pegylated interferon alpha and ribavirin

被引：0
|
作者：
Younossi, Z. M. [1 ]
Baranova, A. [1 ]
Stepanova, M. [1 ]
Afendy, A. [1 ]
Wheeler, A. [1 ]
Hossain, N. [1 ]
Bakshi, A. [1 ]
Santini, C. D. [2 ]
Sigua, C. L. [2 ]
Chan, J. [2 ]
Iverson, A. A. [2 ]
Chang, S. P. [2 ]
机构：
[1] Inova Fairfax Hosp, Ctr Liver Dis, Falls Church, VA USA
[2] Celera, Alameda, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60768-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
766
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [21] Protein Pathway Activation Associated with Sustained Virologic Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon (PEG-IFN) and Ribavirin (RBV)
    Younossi, Zobair M.
    Limongi, Dolores
    Stepanova, Maria
    Pierobon, Mariaelena
    Afendy, Arian
    Mehta, Rohini
    Baranova, Ancha
    Liotta, Lance
    Petricoin, Emanuel
    JOURNAL OF PROTEOME RESEARCH, 2011, 10 (02) : 774 - 779
  • [22] HCV RNA at 12 weeks after treatment can predict sustained virologic response in chronic hepatitis C patients treated with pegylated interferon and ribavirin
    Lee, J. H.
    Yoo, B. C.
    Lee, J. S.
    Kim, H. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A263 - A263
  • [23] Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
    Garib, Junia Rios
    Garcia, Guilherme Freire
    Teixeira, Rosangela
    Lima e Silva, Francisco das Chagas
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (08) : 625 - 631
  • [24] HCV RNA at 12 weeks after treatment can predict sustained virologic response in chronic hepatitis C patients treated with pegylated interferon and ribavirin
    Yang, Sun
    Lee, Joon Hyoek
    Gwak, Geum-Youn
    Choi, Moon Seok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    GASTROENTEROLOGY, 2008, 134 (04) : A830 - A830
  • [25] Predictors of Sustained Virologic Response (SVR) of Chronic Hepatitis C
    Al-Saeed, Abdulwahed
    BAHRAIN MEDICAL BULLETIN, 2011, 33 (02) : 103 - 110
  • [26] Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C
    Martinot-Peignoux, M.
    Comanor, L.
    Minor, J. M.
    Ripault, M. P.
    Pham, B. -N.
    Boyer, N.
    Castelnau, C.
    Giuily, N.
    Hendricks, D.
    Marcellin, Patrick
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (10) : 701 - 707
  • [27] SUSTAINED VIROLOGICAL RESPONSE (SVR) TO PEGYLATED INTERFERON AND RIBAVIRIN HAS NO EFFECT ON NEUROCOGNITION AND CEREBRAL METABOLITE LEVELS IN PATIENTS WITH CHRONIC HEPATITIS C
    Patfullo, Venesso
    Mcandrews, Mary Pat
    Mrkonjic, Mirela
    Domyanovich, Andrei
    Heathcote, E. Jenny
    HEPATOLOGY, 2008, 48 (04) : 539A - 539A
  • [28] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) TO PEGYLATED INTERFERON ALPHA (PEG-IFN alpha) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH GENOTYPE 1
    Antonov, Krasimir
    Jelev, Deian
    Ivanova, A.
    Krastev, Zahariy
    JOURNAL OF IMAB, 2011, 17 (01): : 197 - 199
  • [29] High virologic sustained response for former young intravenous drug users with chronic hepatitis C treated by pegylated interferon-α plus ribavirin
    Gazdik, F.
    Gazdikova, K.
    Laktis, K.
    Okruhlica, L.
    Fejdiova, K.
    Danis, D.
    Pijak, M. R.
    Wsolova, L.
    Kajaba, I
    Kratky, A.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2009, 110 (02): : 77 - 84
  • [30] Early Gene Expression Profiles of Patients with Chronic Hepatitis C Treated with Pegylated Interferon-Alfa and Ribavirin
    Younossi, Zobair M.
    Baranova, Ancha
    Afendy, Arian
    Collantes, Rochelle
    Stepanova, Maria
    Manyam, Ganiraju
    Bakshi, Anita
    Sigua, Christopher L.
    Chan, Joanne P.
    Iverson, Ayuko A.
    Santini, Christopher D.
    Chang, Sheng-Yung P.
    HEPATOLOGY, 2009, 49 (03) : 763 - 774
12345